A Qualitative Study of Barriers and Facilitators to Adherence to Secondary Prevention Medications Among French Patients Suffering from Stroke and Transient Ischemic Attack

References

• Burn J, Dennis M, Bamford J, Sandercock P, Wade D, Warlow C. Long-term risk of recurrent stroke after a first-ever stroke. The Oxfordshire community stroke project. Stroke. 1994;25(2):333–337. doi:10.1161/01.STR.25.2.333
   PubMed Web of Science ®Google Scholar
• Lovett JK, Dennis MS, Sandercock PAG, Bamford J, Warlow CP, Rothwell PM. Very early risk of stroke after a first transient ischemic attack. Stroke. 2003;34(8):e138–140. doi:10.1161/01.STR.0000080935.01264.91
   PubMed Web of Science ®Google Scholar
• Hackam DG, Spence JD. Combining multiple approaches for the secondary prevention of vascular events after stroke: a quantitative modeling study. Stroke. 2007;38(6):1881–1885. doi:10.1161/STROKEAHA.106.475525
   PubMed Web of Science ®Google Scholar
• Park J-H, Ovbiagele B. Optimal combination treatment and vascular outcomes in recent ischemic stroke patients by premorbid risk level. J Neurol Sci. 2015;355(1–2):90–93. doi:10.1016/j.jns.2015.05.028
   PubMed Web of Science ®Google Scholar
• Rothwell PM, Giles MF, Chandratheva A, et al. Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison. Lancet. 2007;370(9596):1432–1442. doi:10.1016/S0140-6736(07)61448-2
   PubMed Web of Science ®Google Scholar
• Rothwell PM, Algra A, Amarenco P. Medical treatment in acute and long-term secondary prevention after transient ischaemic attack and ischaemic stroke. Lancet. 2011;377(9778):1681–1692. doi:10.1016/S0140-6736(11)60516-3
   PubMed Web of Science ®Google Scholar
• Burke JP, Sander S, Shah H, Zarotsky V, Henk H. Impact of persistence with antiplatelet therapy on recurrent ischemic stroke and predictors of nonpersistence among ischemic stroke survivors. Curr Med Res Opin. 2010;26(5):1023–1030. doi:10.1185/03007991003670563
   PubMed Web of Science ®Google Scholar
• Perreault S, Yu AYX, Côté R, Dragomir A, White-Guay B, Dumas S. Adherence to antihypertensive agents after ischemic stroke and risk of cardiovascular outcomes. Neurology. 2012;79(20):2037–2043. doi:10.1212/WNL.0b013e3182749e56
   Web of Science ®Google Scholar
• Cummings DM, Letter AJ, Howard G, et al. Medication adherence and stroke/TIA risk in treated hypertensives: results from the REGARDS study. J Am Soc Hypertens. 2013;7(5):363–369. doi:10.1016/j.jash.2013.05.002
   Web of Science ®Google Scholar
• Xu J, Zhao X, Wang Y, et al. Impact of a better persistence with antihypertensive agents on ischemic stroke outcomes for secondary prevention. PLoS One. 2013;8(6):e65233. doi:10.1371/journal.pone.0065233
   Web of Science ®Google Scholar
• Zhang J, Gong Y, Zhao Y, Jiang N, Wang J, Yin X. Post-stroke medication adherence and persistence rates: a meta-analysis of observational studies. J Neurol. 2019. doi:10.1007/s00415-019-09660-y
   Web of Science ®Google Scholar
• Al AlShaikh S, Quinn T, Dunn W, Walters M, Dawson J. Predictive factors of non-adherence to secondary preventative medication after stroke or transient ischaemic attack: a systematic review and meta-analyses. Eur Stroke J. 2016;1(2):65–75. doi:10.1177/2396987316647187
   PubMed Web of Science ®Google Scholar
• Conrad P. The meaning of medications: another look at compliance. Soc Sci Med. 1985;20(1):29–37. doi:10.1016/0277-9536(85)90308-9
   PubMed Web of Science ®Google Scholar
• Fainzang S. [The Doctor-Patient Relationship: Information and Lies]. Paris: Presses universitaires de France; 2006. French
   Google Scholar
• Bauler S, Jacquin-Courtois S, Haesebaert J, et al. Barriers and facilitators for medication adherence in stroke patients: a qualitative study conducted in French neurological rehabilitation units. Eur Neurol. 2014;72(5–6):262–270. doi:10.1159/000362718
   Web of Science ®Google Scholar
• Souter C, Kinnear A, Kinnear M, Mead G. Optimisation of secondary prevention of stroke: a qualitative study of stroke patients’ beliefs, concerns and difficulties with their medicines. Int J Pharm Pract. 2014;22(6):424–432. doi:10.1111/ijpp.12104
   Google Scholar
• Jamison J, Graffy J, Mullis R, Mant J, Sutton S. Barriers to medication adherence for the secondary prevention of stroke: a qualitative interview study in primary care. Br J Gen Pract. 2016;66(649):e568–576. doi:10.3399/bjgp16X685609
   PubMed Web of Science ®Google Scholar
• Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349–357. doi:10.1093/intqhc/mzm042
   PubMed Web of Science ®Google Scholar
• Xue Y, Haesebaert J, Derex L, et al. Choice of initial brain imaging in patients with suspected acute stroke: STROKE69, a population-based study. Cerebrovasc Dis. 2020:1–9. doi:10.1159/000505960.
   Web of Science ®Google Scholar
• Heiby EM, Carlson JG. The health compliance model. J Compliance Health Care. 1986;1(2):135–152.
   Google Scholar
• Becker MH. Patient adherence to prescribed therapies. Med Care. 1985;23(5):539–555. doi:10.1097/00005650-198505000-00014
   PubMed Web of Science ®Google Scholar
• Pender NJ. A conceptual model for preventive health behavior. Nurs Outlook. 1975;23(6):385–390.
   Google Scholar
• Walsh JM, McPhee SJ. A systems model of clinical preventive care: an analysis of factors influencing patient and physician. Health Educ Q. 1992;19(2):157–175. doi:10.1177/109019819201900202
   PubMedGoogle Scholar
• Sabaté E, Organization WH. Adherence to Long-Term Therapies: Evidence for Action. World Health Organization; 2003.
   Google Scholar
• Bardin L. [The Content Analysis]. Paris: Presses universitaires de France; 2007.French
   Google Scholar
• Paillé P, Mucchielli A. [Qualitative Analysis in the Humanities and Social Sciences]. Paris: A. Colin; 2013.French
   Google Scholar
• Della Vecchia C, Préau M, Carpentier C, et al. Illness beliefs and emotional responses in mildly disabled stroke survivors: a qualitative study. PLoS One. 2019;14(10):e0223681. doi:10.1371/journal.pone.0223681
   PubMed Web of Science ®Google Scholar
• Ruiter RAC, Kessels LTE, Peters G-JY, Kok G. Sixty years of fear appeal research: current state of the evidence. Int J Psychol. 2014;49(2):63–70. doi:10.1002/ijop.12042
   PubMed Web of Science ®Google Scholar
• Moscovici S. [Psychoanalysis, Its Image and Audience]. 3rd ed. Paris: Presses universitaires de France; 1961.French
   Google Scholar
• Moscovici S. [The Scandal of Social Thought: Unpublished Texts on Social Representations Collected and Prefaced by Nikos Kalampalikis]. Editions de l’Ecole des hautes études en science sociale; 2013.French
   Google Scholar